Genome-wide association study of HPV seropositivity

Human Molecular Genetics

Volumn 20, Issue 23, 2011, Pages 4714-4723

  Chen, Dan ^a   McKay, James D ^a   Clifford, Gary ^a   Gaborieau, Valérie ^a   Chabrier, Amélie ^a   Waterboer, Tim ^b   Zaridze, David ^c   Lissowska, Jolanta ^d   Rudnai, Peter ^e   Fabianova, Eleonora ^f   Bencko, Vladimir ^g   Janout, Vladimir ^h   Foretova, Lenka ⁱ   Mates, Ioan Nicolae ^j   Szeszenia Dabrowska, Neonila ^k   Curado, Maria Paula ^l   Koifman, Sergio ^m   Menezes, Ana ⁿ   Wünsch Filho, Victor ^o   Eluf Neto, José ^o   Garrote, Leticia Fernández ^p   Matos, Elena ^q   Zelenika, Diana ^r   Boland, Anne ^r   Boffetta, Paolo ^l,s   Pawlita, Michael ^b   Lathrop, Mark ^r,t   Brennan, Paul ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^d INSTITUTE OF ONCOLOGY   (Poland)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH   (Hungary)

^f State Institute of Public Health Slovakia   (Slovakia)

^g CHARLES UNIVERSITY   (Czech Republic)

^h PALACKÝ UNIVERSITY   (Czech Republic)

ⁱ MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^j CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^k NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^l INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^m INSTITUTO OSWALDO CRUZ   (Brazil)

ⁿ FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^o UNIVERSITY OF SÃO PAULO   (Brazil)

^p INSTITUTO NACIONAL DE ONCOLOGÍA Y RADIOBIOLOGÍA   (Cuba)

^q UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^r CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^s MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^t FONDATION JEAN DAUSSET CEPH   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEAD AND NECK CANCER; HUMAN; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTICENTER STUDY; PRIORITY JOURNAL; RISK; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; WART VIRUS;

EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOME-WIDE ASSOCIATION STUDY; HIV ANTIBODIES; HIV SEROPOSITIVITY; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS;

HUMAN PAPILLOMAVIRUS; MIRIDAE;

EID: 81255169291     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr383     Document Type: Article

References (53)

1. de Villiers, E.M., Fauquet, C., Broker, T.R., Bernard, H.U. and zur Hausen, H. (2004) Classification of papillomaviruses. Virology, 324, 17-27.
2. Muñoz, N., Bosch, F.X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K.V., Snijders, P.J. and Meijer, C.J. and International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med., 348, 518-527.
3. Narechania, A., Chen, Z., DeSalle, R. and Burk, R.D. (2005) Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J. Virol., 79, 15503-15510.
4. Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., E.l. Ghissassi, F., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L. et al. (2009) A review of human carcinogens-Part B: biological agents. Lancet Oncol., 10, 321-322.
5. Jablonska, S., Majewski, S., Obalek, S. and Orth, G. (1997) Cutaneous warts. Clin. Dermatol., 15, 309-319.
6. Gassenmaier, A., Fuchs, P., Schell, H. and Pfister, H. (1986) Papillomavirus DNA in warts of immunosuppressed renal allograft recipients. Arch. Dermatol. Res., 278, 219-223.
7. Akgul, B., Cooke, J.C. and Storey, A. (2006) HPV-associated skin disease. J. Pathol., 208, 165-175.
8. Nindl, I., Gottschling, M. and Stockfleth, E. (2007) Human papillomaviruses and nonmelanoma skin cancer: basic virology and clinical manifestations. Dis. Markers, 23, 247-259.
9. Masini, C., Fuchs, P.G., Gabrielli, F., Stark, S., Sera, F., Ploner, M., Melchi, C.F., Primavera, G., Pirchio, G., Picconi, O. et al. (2003) Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch. Dermatol., 139, 890-894.
10. Karagas, M.R., Waterboer, T., Li, Z., Nelson, H.H., Michael, K.M., Bavinck, J.N., Perry, A.E., Spencer, S.K., Daling, J. et al. (2010) Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ, 341, c2986.
11. Feltkamp, M.C., Broer, R., di Summa, F.M., Struijk, L., van der Meijden, E., Verlaan, B.P., Westendorp, R.G., ter Schegget, J., Spaan, W.J. and Bouwes Bavinck, J.N. (2003) Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res., 63, 2695-2700.
12. Jablonska, S. and Majewski, S. (1994) Epidermodysplasia verruciformis: immunological and clinical aspects. Curr. Top. Microbiol. Immunol., 186, 157-175.
13. Munger, K. and Howley, P.M. (2002) Human papillomavirus immortalization and transformation functions. Virus Res., 89, 213-228.
14. Stanley, M. (2006) Immune responses to human papillomavirus. Vaccine, 24, S16-S22.
15. Wang, S.S., Schiffman, M., Herrero, R., Carreon, J., Hildesheim, A., Rodriguez, A.C., Bratti, M.C., Sherman, M.E., Morales, J., Guillen, D. et al. (2004) Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica. Br. J. Cancer., 91, 1269-1274.
16. Konya, J. and Dillner, J. (2001) Immunity to oncogenic human papillomaviruses. Adv. Cancer Res., 82, 205-238.
17. Coursaget, P. (2003) Serology for human papillomavirus. Salud. Publica. Mex., 45, S361-S366.
18. Frazer, I.H. (2009) Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology, 384, 410-414.
19. de Bakker, P.I., McVean, G., Sabeti, P.C., Miretti, M.M., Green, T., Marchini, J., Ke, X., Monsuur, A.J., Whittaker, P., Delgado, M. et al. (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet., 38, 1166-1172.
20. Durbin, R.M., Abecasis, G.R., Altshuler, D.L., Auton, A., Brooks, L.D., Durbin, R.M., Gibbs, R.A., Hurles, M.E. and McVean, G.A. 1000 Genomes Project Consortium. (2010) A map of human genome variation from population-scale sequencing. Nature, 467, 1061-1073.
21. Antonsson, A., Karanfilovska, S., Lindqvist, P.G. and Hansson, B.G. (2003) General acquisition of human papillomavirus infections of skin occurs in early infancy. J. Clin. Microbiol., 41, 2509-2514.
22. Antonsson, A., Forslund, O., Ekberg, H., Sterner, G. and Hansson, B.G. (2000) The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J. Virol., 74, 11636-11641.
23. Kohler, A., Forschner, T., Meyer, T., Ulrich, C., Gottschling, M., Stockfleth, E. and Nindl, I. (2007) Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas. Br. J. Dermatol., 156, 1078-1080.
24. Hazard, K., Karlsson, A., Andersson, K., Ekberg, H., Dillner, J. and Forslund, O. (2007) Cutaneous human papillomaviruses persist on healthy skin. J. Invest. Dermatol., 127, 116-119.
25. de Koning, M.N., Struijk, L., Bavinck, J.N., Kleter, B., ter Schegget, J., Quint, W.G. and Feltkamp, M.C. (2007) Betapapillomaviruses frequently persist in the skin of healthy individuals. J. Gen. Virol., 88, 1489-1495.
26. Michael, K.M., Waterboer, T., Sehr, P., Rother, A., Reidel, U., Boeing, H., Bravo, I.G., Schlehofer, J., Gärtner, B.C. and Pawlita, M. (2008) Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog., 4, e1000091.
27. Steger, G., Olszewsky, M., Stockfleth, E. and Pfister, H. (1990) Prevalence of antibodies to human papillomavirus type 8 in human sera. J. Virol., 64, 4399-4406.
28. Weissenborn, S.J., Nindl, I., Purdie, K., Harwood, C., Proby, C., Breuer, J., Majewski, S., Pfister, H. and Wieland, U. (2005) Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J. Invest. Dermatol., 125, 93-97.
29. Favre, M., Majewski, S., Noszczyk, B., Maienfisch, F., Pura, A., Orth, G. and Jablonska, S. (2000) Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J. Invest. Dermatol., 114, 403-407.
30. Favre, M., Orth, G., Majewski, S., Baloul, S., Pura, A. and Jablonska, S. (1998) Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J. Invest. Dermatol., 110, 311-317.
31. Dillner, J. (1999) The serological response to papillomaviruses. Semin. Cancer Biol., 9, 423-430.
32. Waterboer, T., Neale, R., Michael, K.M., Sehr, P., de Koning, M.N., Weissenborn, S.J., Sampogna, F., Abeni, D., Green, A.C., Bouwes Bavinck, J.N. and Pawlita, M. (2009) Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J. Gen. Virol., 90, 1986-1998.
33. Stanley, M.A. (2009) Immune responses to human papilloma viruses. Indian J. Med. Res., 130, 266-276.
34. Mahmud, S.M., Robinson, K., Richardson, H., Tellier, P.P., Ferenczy, A.S., Roger, M., Coutlee, F. and Franco, E.L. (2007) HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students. J. Infect. Dis., 196, 82-90.
35. Beskow, A.H., Josefsson, A.M. and Gyllensten, U.B. (2001) HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int. J. Cancer., 93, 817-822.
36. Beskow, A.H. and Gyllensten, U.B. (2002) Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int. J. Cancer., 101, 526-531.
37. Maciag, P.C., Schlecht, N.F., Souza, P.S., Rohan, T.E., Franco, E.L. and Villa, L.L. (2002) Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection. J. Infect. Dis., 186, 164-172.
38. de Araujo Souza, P.S., Sichero, L. and Maciag, P.C. (2009) HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncol., 5, 359-370.
39. Iannacone, M.R., Michael, K.M., Giuliano, A.R., Waterboer, T., Pawlita, M. and Rollison, D.E. (2010) Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida. J. Infect. Dis., 201, 760-769.
40. Heath, S.C., Gut, I.G., Brennan, P., McKay, J.D., Bencko, V., Fabianova, E., Foretova, L., Georges, M., Janout, V., Kabesch, M. et al. (2008) Investigation of the fine structure of European populations with applications to disease association studies. Eur. J. Hum. Genet., 16, 1413-1429.
41. Hung, R.J., McKay, J.D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P. et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452, 633-637.
42. Hashibe, M., McKay, J.D., Curado, M.P., Oliveira, J.C., Koifman, S., Koifman, R., Zaridze, D., Shangina, O., Wünsch-Filho, V., Eluf-Neto, J. et al. (2008) Multiple ADH genes are associated with upper aerodigestive cancers. Nat. Genet., 40, 707-709.
43. Waterboer, T., Sehr, P., Michael, K.M., Franceschi, S., Nieland, J.D., Joos, T.O., Templin, M.F. and Pawlita, M. (2005) Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin. Chem., 51, 1845-1853.
44. Waterboer, T., Sehr, P. and Pawlita, M. (2006) Suppression of non-specific binding in serological Luminex assays. J. Immunol. Methods, 309, 200-204.
45. Clifford, G.M., Shin, H.R., Oh, J.K., Waterboer, T., Ju, Y.H., Vaccarella, S., Quint, W., Pawlita, M. and Franceschi, S. (2007) Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol. Biomarkers Prev., 16, 1874-1879.
46. Ribeiro, K.B., Levi, J.E., Pawlita, M., Koifman, S., Matos, E., Eluf-Neto, J., Wunsch-Filho, V., Curado, M.P., Shangina, O., Zaridze, D. et al. (2011) Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int. J. Epidemiol., 40, 489-502.
47. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
48. Falush, D., Stephens, M. and Pritchard, J.K. (2003) Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics, 164, 1567-1587.
49. Yu, K., Wang, Z., Li, Q., Wacholder, S., Hunter, D.J., Hoover, R.N., Chanock, S. and Thomas, G. (2008) Population substructure and control selection in genome-wide association studies. PloS ONE, 3, 2551.
50. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A. and Reich, D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.
51. Aulchenko, Y.S., Struchalin, M.V. and van Duijn, C.M. (2010) ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics, 11, 134.
52. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
53. Traherne, J.A. (2008) Human MHC architecture and evolution: implications for disease association studies. Int. J. Immunogenet., 35, 179-192.